Dublin, December 23, 2022 /PR Newswire/ — “Global Biosimulation Market (2022 Edition) – Analysis by Component (Software, Services), Application (Drug Discovery, Preclinical, Clinical), End User, Region and Country: Market Insights and Forecasts (2018-2028) ” report added of ResearchAndMarkets.com Recruitment.
The global biosimulation market is US$3,011.5 million Biosimulation helps increase the odds of success in human clinical trials, the most expensive part of drug development.
Biosimulation can help optimize dosages for different populations to increase safety and efficacy. New drugs can trigger a significant increase in retail spending because they are more expensive, in high demand, or both. Currently, in silico methods have surpassed various stages of drug discovery, especially in the biomedical sciences.
In biosimulation drug discovery, there are many opportunities to eliminate errors through computer simulation. This can improve the performance and accuracy of pharmaceuticals. In the coming years, the biosimulation market is likely to thrive due to expanding applications and increasing use of personalized medicine and biosimulation solutions for pediatric drug development.
Companies around the world use critical strategies such as component launches, business expansions, mergers and acquisitions, patents and approvals, contracts and collaborations.
The major software methods in drug development are structure-based drug design, molecular modeling, structure-based virtual screening, ligand interaction, and molecular dynamics.
New technologies such as virtual reality and artificial intelligence (AI) are expanding opportunities for drug discovery. The Americas are experiencing favorable growth in the biosimulation industry, usa continues to be the earliest launch country with 72 NAS launched in 2021.
Reporting scope
-
The report presents an analysis of the biosimulation market for the historical period 2018-2021, the estimated year 2022, and the forecast period 2023-2028.
-
This report analyzes the biosimulation market by value (million USD).
-
The report analyzes the bio-simulation market by component (software, services).
-
The report analyzes the biosimulation market by application (drug discovery, preclinical, clinical).
-
This report analyzes the biosimulation market by end-user (academic and government research institutes, pharmaceutical and biotechnology companies, contract research institutes, and regulators).
-
The global biosimulation market is analyzed by country (America, Canada, Mexico, Germany, England, France, Italy, China, Japan, India).
-
Market attractiveness is presented by region, by component, by application, and by end-user.
-
The report also analyzes key industry opportunities, trends, drivers, and challenges.
competitive environment
This report tracks competitive developments, strategies, mergers and acquisitions, and new product development.
Companies analyzed in the report include:
Main topics:
1.First of all
1.1 Overview of biosimulation
1.2 Scope of research
2. Abstract
2.1 Market Dashboard
2.2 Regional Insights
2.3 Market ecosystem factors
3. Survey method
3.1 Data collection process
3.2 Market Trajectory Estimation
3.3 Market size calculation
4. Market dynamics
4.1 Driver
4.2 Constraints
4.3 Opportunities
4.4 Trends
4.5 Assessing the impact of market dynamics
5. Value chain analysis
5.1 Research and development
5.2 Key Developers and Providers
5.3 Top 10 pharmaceutical companies
5.4 End-use industries
6. Covid-19 Impact Assessment
6.1 Assessing the impact of Covid-19 on biosimulation market
6.2 Quarterly Covid Impact Analysis by Region
7. Porter’s Five Forces Analysis
8. Macroeconomic outlook
8.1 Growth of the pharmaceutical industry
8.2 Global healthcare costs
8.3 Global biopharmaceutical R&D spending
8.4 Drugs under development
8.5 Global Software Industry
9. Average Selling Price Analysis
9.1 Average Sales Price by Region
9.2 Average Selling Price by Component
10. Competitive positioning
10.1 Positioning of corporate components
10.2 Market position matrix
10.3 Market Share Analysis
11. Global Biosimulation Market Trends and Forecast Analysis, 2018-2028, USD Million and CAGR
11.1 Macroeconomic Factor Impact Index
11.2 Global Biosimulation Market: Dashboard
11.3 Global Biosimulation Market Size, By Value, 2018-2021 (USD Million)
11.4 Global Biosimulation Market Size, By Value, 2022-2028 (Million USD)
11.5 Global Biosimulation Market: An Overview
12. Global Biosimulation Market Trends and Forecast Analysis, 2018-2028, By Component
12.1 Global Biosimulation Market Trends and Forecast Analysis, By Components: Snapshot
12.2 Software
12.3 Services
13. Global Biosimulation Market Trends and Forecast Analysis, 2018-2028, By Application
13.1 Global Biosimulation Market Trends and Forecast Analysis, By Application: Snapshot
13.2 Drug Discovery
13.3 Preclinical
13.4 Clinical
14. Global Biosimulation Market Trends and Forecast Analysis, 2018-2028, By End User
14.1 Global Biosimulation Market Trends and Forecast Analysis, By End User: Snapshot
14.2 Academic and government research institutions
14.3 Pharmaceutical and biotech companies
14.4 Contract Research Institutions
14.5 Regulatory Authorities
15. Global Biosimulation Market Trends and Forecast Analysis, 2018-2028, By Region
15.1 Survey Area
Learn more about this report here https://www.researchandmarkets.com/r/d4jlai
Media contact:
research and market
Laura WoodSenior Manager
press@researchandmarkets.com
For EST office hours, please call +1-917-300-0470.
US/Canada Toll Free +1-800-526-8630
For GMT office hours, please call +353-1-416-8900.
US Fax: 646-607-1907
Fax (outside US): +353-1-481-1716
logo: https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg
SOURCE Research and Market
